Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - PharmaCyte Biotech, Inc. | pharmacyte_10k-043021.htm |
| EX-32.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_ex3202.htm |
| EX-32.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_ex3201.htm |
| EX-31.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_ex3102.htm |
| EX-31.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_ex3101.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - PharmaCyte Biotech, Inc. | pharmacyte_ex2101.htm |
| EX-4.2 - DESCRIPTION OF SECURITIES - PharmaCyte Biotech, Inc. | pharmacyte_ex0402.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-255044) of PharmaCyte Biotech, Inc. of our report dated August 9, 2021 relating to the consolidated financial statements and consolidated financial statement schedules, which appears in this Form 10-K for the year ended April 30, 2021 listed in the accompanying index.
/s/ ArmaninoLLP
San Jose, California
August 9, 2021